Data / Form D filings / LEXICON PHARMACEUTICALS, INC.
LEXICON PHARMACEUTICALS, INC.: Form D filings
LEXICON PHARMACEUTICALS, INC., a pharmaceuticals company in The Woodlands, TX, filed 8 Form D notices with the SEC between 2010 and 2026. The latest, on February 17, 2026, reports $55.7 million sold of a $59.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2445 Technology Forest Blvd., 11th Floor, The Woodlands, TX, 77381
- Phone
- (281) 863-3000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1062822
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | New notice | $59,150,000 | $55,668,255 | $3,481,745 | 1 | Feb 2, 2026 | sec.gov |
| Jun 20, 2023 | New notice | $72,215,130 | $72,215,130 | 1 | Jun 5, 2023 | sec.gov | |
| Aug 3, 2022 | New notice | $49,324,650 | $42,891,000 | $6,433,650 | 2 | Aug 1, 2022 | sec.gov |
| Mar 24, 2017 | New notice | $10,506,500 | $10,506,500 | 16 | Mar 21, 2017 | sec.gov | |
| Dec 12, 2014 | New notice | $4,662,780 | $4,662,780 | 16 | Dec 4, 2014 | sec.gov | |
| Dec 8, 2014 | New notice | $150,000,000 | $150,000,000 | 1 | Nov 26, 2014 | sec.gov | |
| Aug 7, 2012 | New notice | $35,000,000 | $35,000,000 | 16 | Jul 30, 2012 | sec.gov | |
| Mar 31, 2010 | New notice | $75,035,737 | $75,035,737 | 2 | Mar 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Raymond Debbane | Director | |
| Phillipe J. Amouyal | Director | |
| Samuel Barker | Director | |
| Ivan H. Cheung | Director | |
| Scott Coiante | Executive Officer | |
| Brian T. Crum | Executive Officer | |
| Lisa DeFrancesco | Executive Officer | |
| Mike Exton | Executive Officer, Director | |
| Rachel Martens | Executive Officer | |
| Suma Gopinathan | Executive Officer | |
| Craig B. Granowitz | Executive Officer | |
| Rachel Martens | Executive Officer | |
| Wendy E. McDermott | Executive Officer | |
| Christopher Sobecki | Director | |
| Diane E. Sullivan | Director | |
| Judith L. Swain | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Feb 16, 2026 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LEXICON PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.